DMAC
DiaMedica Therapeutics Inc.$8.30-0.49 (-5.57%)Prev Close$8.79·MCap$474.3M·P/E—·Vol190.3K·Yield—
▲
Buys (12M)
1
$7.63M
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$7.63M
●
Active Insiders
1
last 12 mo
Over the past 12 months, insider activity at DiaMedica Therapeutics Inc. (DMAC) has been exclusively buying, with 1 insider purchase totaling $7.63M and 0 insider sales totaling $0.00. The most recent insider transaction was by STAHLBERG JAN (10% Owner), who purchased $7.63M worth of shares on Nov 17, 2025. DiaMedica Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $474.3M.
DMAC Insider Trading Activity
DMAC Insider Buying Activity
The following table shows recent insider purchases of DiaMedica Therapeutics Inc. (DMAC) stock reported via SEC Form 4 filings.
DMAC Insider Selling Activity
The following table shows recent insider sales of DiaMedica Therapeutics Inc. (DMAC) stock reported via SEC Form 4 filings.